Clinicians will have access to data on adverse CV outcomes, care.
89% have OSA after other possible causes of hypertension are excluded.
Diagnosis should be considered in babies with refractory hypoxemia of mothers with DM.
The oral treprostinil group achieved 26% reduction in clinical worsening.
Recommendations based on functional class, right ventricular function, BNP/NT-proBNP and six-minute walking test.
Small meta-analysis finds no effect on FEV1.
Improvements in PVR and other hemodynamic parameters after 16 weeks in an open-label trial.
Questa sessione informa su otto studi di valutazione di nuovi medicamenti e interventi nel trattamento dell'interstiziopatia polmonare e dell'ipertensione polmonare.
New diagnostic criteria, risk factors for outcomes, treatment algorithms, graded recommendations.
Un ampio studio condotto in Australia mostra che anche valori inferiori a quelli considerati borderline sono predittivi di un aumento del rischio di mortalità a 5 anni.
Patients receiving Xvivo-supported lungs survived as long as those whose donor lungs did not require support.
Due studi di associazione e una metanalisi hanno messo in luce l’esistenza del legame di alcune rare varianti genomiche con il rischio e la sopravvivenza legati alla patologia.
Endorsed by international organisations including the European Society of Clinical Microbiology and Infectious Diseases and the Society for Critical Care Medicine.
Cochrane review finds mixed evidence for PH related to left-heart disease.
Targeting the neurohumoral component of CpcPH may be beneficial.
Guidelines incorporate additional research since 2014.
Carefully monitored exercise in a rehab setting brings many benefits to stable patients.
